LCID
Lucid Group, Inc.
LCID has a slight edge over MMYT overall, supported by stronger fundamentals and stronger valuation.
MMYT
MakeMyTrip Limited
MMYT has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MMYT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Weak |
MMYT's profitability is currently healthy, and its revenue is stable, but its cash flow and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MMYT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 41x | $51.01 | — |
| Cheap | 56x | $18.60 | -64% |
| Fair | 113x | $37.14 | -27% |
| Expensive | 155x | $51.30 | +0.6% |
| Current | 156x | $51.01 | — |
Historical ranges are pointers, not guarantees.
MMYT's PE is in its expensive range at 156x. If earnings grow as analysts expect, today's price would be 41x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MMYT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MMYT, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MMYT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.24 | +276% |
| Q3 2026 | $0.33 | -48% |
| Q2 2026 | $0.33 | -62% |
| Q1 2026 | $0.47 | -43% |
| Q4 2025 | $0.49 | -73% |
| Q3 2025 | $0.64 | -65% |
| Q2 2025 | $0.86 | -49% |
| Q1 2025 | $0.83 | -50% |
| Q4 2024 | $1.84 | +300% |
MMYT has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MMYT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MMYT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $229.3M | 0% |
| Q2 2026 | $285.6M | +6.2% |
| Q1 2026 | $250.1M | +1.9% |
| Q4 2025 | $295.7M | +11% |
| Q3 2025 | $229.3M | +8.7% |
| Q2 2025 | $268.8M | +5.6% |
| Q1 2025 | $245.5M | +21% |
| Q4 2024 | $267.4M | +25% |
MMYT's revenue is growing: $229M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | 0 points |
| Q2 2026 | 15% | +0.3 points |
| Q1 2026 | 16% | +3.3 points |
| Q4 2025 | 14% | +0.9 points |
| Q3 2025 | 15% | +2.6 points |
| Q2 2025 | 15% | +4.1 points |
| Q1 2025 | 13% | +4.5 points |
| Q4 2024 | 13% | +2.4 points |
MMYT has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MMYT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $0 | -100% |
| Q2 2026 | $0 | -100% |
| Q1 2026 | $0 | -100% |
| Q4 2025 | $45.6M | +$56.1M |
| Q3 2025 | $48.7M | +37% |
| Q2 2025 | $41.8M | -42% |
| Q1 2025 | $87.8M | +$94.4M |
| Q4 2024 | -$10.5M | -115% |
MMYT has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MMYT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -220K shares |
| 1 year | 0% | -- |
| 3 years | -13% | -14.5M shares |
| 5 years | -9.7% | -10.5M shares |
| Available history | -6.9% | -7.3M shares |
MMYT has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1.6B |
| Q3 2025 | $3B |
| Q2 2025 | — |
| Q1 2025 | $7M |
| Q4 2024 | — |
MMYT spent $1.6B buying back its own shares over the past year, down 47% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MMYT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.3x | High |
| Q2 2026 | 6.2x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 6.7x | High |
| Q3 2025 | 6.3x | High |
| Q2 2025 | 5.1x | High |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
MMYT's net debt is about 6.3 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MMYT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 37.3 | Neutral |
MMYT's weekly RSI is 50 (neutral) and its Stochastic is 37 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MMYT PE vs Consumer Cyclical Sector
| Metric | MMYT | Sector median | Relative |
|---|---|---|---|
| PE | 156x | 18x | 763% above |
| PE % | 83 | 47 | 36 pts above |
MMYT is trading at 156x earnings, a 763% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MMYT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.2 | 10% above |
| 20 week MA | $52.0 | 2% below |
| 50 week MA | $54.4 | 6.2% below |
| 100 week MA | $76.1 | 33% below |
| 200 week MA | $66.9 | 24% below |
MMYT has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MMYT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.6 | $27.2 | +15% |
| 2021 | $27.2 | $28.3 | +4.1% |
| 2022 | $28.3 | $28.0 | -1.1% |
| 2023 | $28.0 | $47.0 | +68% |
| 2024 | $47.0 | $114.5 | +144% |
| 2025 | $114.5 | $83.3 | -27% |
| 2026 YTD | $83.3 | $51.0 | -39% |
MMYT has the edge over LCID on returns for 2026, with the stronger performance.